Genomenon Announces Publication of Scientific Paper in Frontiers in Genetics
Share Article
Peer-Reviewed Paper Demonstrates the Utility and Superiority of Mastermind for Clinical Diagnostic Variant Interpretation
“This is just the first chapter in our journey to save and improve lives by making genomic information actionable.” Mark Kiel, MD, PhD. Co-Founder, Genomenon ANN ARBOR, Mich. (PRWEB) January 26, 2021
Genomenon, Inc., an AI-driven genomics company that connects the world’s genomic knowledge with patient DNA, announced that a seminal paper written by its team of scientists has been published in the Computational Genomics section of Frontiers in Genetics. Frontiers in Genetics is an open-access journal that publishes rigorously peer-reviewed research on genes and genomes relating to all domains of life.